Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 11 to 14 amino acid residues in defined sequence
Patent
1986-06-17
1987-12-08
Kight, John
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
11 to 14 amino acid residues in defined sequence
530328, 530329, 530330, 530301, C07K 706, C07K 748
Patent
active
047119527
ABSTRACT:
Novel peptide analogs of the serum thymic factor are disclosed, structurally modified, in comparison with the natural substance, both in their N-terminal and C-terminal parts and inside the amino-acid sequence, corresponding to the general formula I
REFERENCES:
patent: 4148886 (1979-04-01), Bach et al.
patent: 4301065 (1981-11-01), Bach et al.
patent: 4320118 (1982-03-01), White et al.
Chemical Abstract 96(19)=163217x, Yanaihara et al. Eur. Pat. Appl. Ep 43247 (1982).
Fok et al., Molecular Immunology, vol. 19, No. 12, pp. 1667-1673, (1982).
Synthesis and Relationship of L-Glutaminyl-L-Histidyl-L-Prolinamide to the Thyrotropin Releasing Hormone.
Cerny Martin
Kasafirek Evzen
Kocis Petr
Krepelka Jiri
Rovensky Jozef
Chan Christina
Kight John
SPOFA, spojene podniky pro zdravotnickouvyrobu
LandOfFree
Serum thymic factor peptide analogs and process for the preparat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serum thymic factor peptide analogs and process for the preparat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serum thymic factor peptide analogs and process for the preparat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-23233